Investment
Features
FeesSafety
Academy
More
Pluang+

Compare International Flavors & Fragrances Inc. Common Stock (IFF) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance

International Flavors & Fragrances Inc. Common StockTrade
Revolution Medicines Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

International Flavors & Fragrances Inc. Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? International Flavors & Fragrances Inc. Common Stock trades at $84.65 (market cap $21.46B), while Revolution Medicines Inc. Common Stock trades at $189 (market cap $43.07B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 2× International Flavors & Fragrances Inc. Common Stock's market cap, and International Flavors & Fragrances Inc. Common Stock pays a 1.9% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Flavors & Fragrances Inc. Common Stock for 0 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.

IFFRVMD
Market Cap
$21.46B$43.07B
Volume
2,398,7811,184,841
Sector
Basic MaterialsHealth
52-Week High
$88.07$221.15
52-Week Low
$59.55$47.50
Typical Hold Time
0 Days0 Days
Enterprise Value
$27.13B$39.77B
Dividend Yield
1.9%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IFF
100% Buy0% Sell
Avg holding period · 0 Days
RVMD
100% Buy0% Sell
Avg holding period · 0 Days

About International Flavors & Fragrances Inc. Common Stock

International Flavors & Fragrances develops ingredients and solutions used in food, beverages, personal care, home care, health, and biosciences applications. Its portfolio includes flavors, fragrances, cultures, enzymes, and nutrition ingredients.

Read more on IFF →

About Revolution Medicines Inc. Common Stock

Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.

Read more on RVMD →